Search Results 461-470 of 17147 for nivolumab

  1. Publications - Muhamad Alhaj Moustafa, M.D., M.S. - Mayo Clinic

    ... Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. J Blood Med. 2024; 15:29-34 Epub 2024 Jan 24. View PubMed; Alhaj Moustafa M, Parrondo R ...

  2. Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as cisplatin ...

  3. Malignant peripheral nerve sheath tumors - Doctors and departments - Mayo Clinic

    These cancers form in the linings of nerves. Treatment includes surgery, radiation therapy and, sometimes, chemotherapy.

  4. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this study is to assess tumor cells from blood and bone marrow from patients with myeloid neoplasms for epigenetic dysregulation ...

  5. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Monoclonal antibodies, such as anetumab ravtansine and atezolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility.

  6. Lenvatinib (oral route) - Side effects & dosage - Mayo Clinic

    Lenvatinib is also used in combination with pembrolizumab injection as first-line treatment of advanced renal cell carcinoma (RCC), a kind of kidney cancer, in ...

  7. Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic

    To this end, many were looking forward to the REGONIVO trial with regorafenib/nivolumab data as well as the data with regorafenib/avelumab. Initial results ...

  8. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

    ... nivolumab, MEDI36MEDI4376, or GNE PDL1 [MPDL3280A]) All Patients; Aged 18 years or older on the day written informed consent is given. If has brain ...

  9. Nephrology and Hypertension - Clinical trials

    In-home Versus In-Clinic Subcutaneous Nivolumab Administration Through Connected And Remote Cancer CARE Beyond Walls. Jacksonville, Fla. The purpose of this ...

  10. A Study of Lenalidomide Combined with a Standard Chemotherapy for Treating Patients with Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma - Mayo Clinic

    Lenalidomide may stop the growth of peripheral T-cell non-Hodgkin's lymphoma by blocking the growth of new blood vessels necessary for cancer growth. Giving ...